β2-adrenoceptors kick osteoarthritis - Time to rethink prevention and therapy

Area of Science:

• Neuroendocrinology
• Rheumatology
• Pharmacology

Background:

• Osteoarthritis (OA) pathogenesis involves local and systemic factors, with neuroendocrine mechanisms often overlooked.
• The sympathetic nervous system (SNS) plays a significant role in OA progression.
• The β2-adrenoceptor (AR) is a key mediator of SNS-driven OA effects.

Purpose of the Study:

• To review the OA-promoting role of the β2-adrenoceptor (AR) over the past two decades.
• To highlight the involvement of the SNS and β2-AR in joint tissues affected by OA.
• To stimulate research into novel therapeutic strategies targeting the β2-AR for OA prevention and treatment.

Main Methods:

• Literature review of in vitro, in vivo, and clinical studies.
• Analysis of research on sympathetic nervous system involvement in osteoarthritis.
• Synthesis of findings related to β2-adrenoceptor function in OA.

Main Results:

• Evidence confirms the β2-adrenoceptor mediates significant OA-promoting effects in joint tissues.
• Multiple studies demonstrate the role of β2-AR in OA initiation and progression.
• The SNS, via β2-AR, influences various components of the OA joint.

Conclusions:

• The β2-adrenoceptor is a critical factor in osteoarthritis pathogenesis.
• Targeting the β2-adrenoceptor presents a promising avenue for developing new OA treatments.
• Further research is warranted to explore innovative therapeutic strategies focused on the β2-AR pathway in OA.